Clovis Oncology Inc. (CLVS) Drops 12.79% on January 11

Equities Staff |

Clovis Oncology Inc. (CLVS) was one of the Russell 2000's biggest losers for Monday January 11 as the stock slid 12.79% to $25.44, a loss of $-3.73 per share. Starting at an opening price of $29.37 a share, the stock traded between $25.33 and $29.76 over the course of the trading day. Volume was 1.43 million shares over 11,903 trades, against an average daily volume of 1.76 million shares and a total float of 38.32 million.

The losses send Clovis Oncology Inc. down to a market cap of $974.88 million. In the last year, Clovis Oncology Inc. has traded between $116.75 and $24.50, and its 50-day SMA is currently $49.88 and 200-day SMA is $77.54.

Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets.

Clovis Oncology Inc. is based out of Boulder, CO and has some 136 employees. Its CEO is Patrick J. Mahaffy.

For a complete fundamental analysis analysis of Clovis Oncology Inc., check out’s Stock Valuation Analysis report for CLVS. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Lithium-X Energy Corp.

Lithium X Energy Corp is engaged in exploring and developing lithium resources. Its projects portfolio includes Albemarle's Silver Peak brine evaporation pond project.

Private Markets

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…

Almond Smart Home Router by Securifi

Securifi sells user friendly touch screen routers that also have support for IoT/home automation.Securifi’s Almond revolutionized wireless router setup with its easy to use Touchscreen Interface in 2012. Now our…